Thioredoxin-related protein 14, a new member of the thioredoxin family with disulfide reductase activity: Implication in the redox regulation of TNF-α signaling

Free Radical Biology and Medicine

Volumn 47, Issue 9, 2009, Pages 1294-1303

  Jeong, Woojin ^a   Jung, Yuyeon ^a   Kim, Hojin ^a   Park, Sun Joo ^a   Rhee, Sue Goo ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Apoptosis; Cysteine oxidation; Disulfide reductase; Dynein light chain LC8; Mitogen activated protein kinases; Nuclear factor B; Redox regulation; Thioredoxin family; Thioredoxin related protein 14; Tumor necrosis factor

Indexed keywords

I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; THIOREDOXIN 1; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1; THIOREDOXIN RELATED PROTEIN 14; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ENZYME ACTIVE SITE; GENE EXPRESSION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; THIOREDOXINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349823268     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.07.021     Document Type: Review

References (119)

1. Rhee S.G., Bae Y.S., Lee S.-R., and Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Science's STKE 2000 (2000) pe1
2. Rhee S.G., Chang T.S., Bae Y.S., Lee S.R., and Kang S.W. Cellular regulation by hydrogen peroxide. J. Am. Soc. Nephrol. 14 (2003) S211-S215
3. Holmgren A. Thioredoxin. Annu. Rev. Biochem. 54 (1985) 237-271
4. Powis G., and Montfort W.R. Properties and biological activities of thioredoxins. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 261-295
5. Nakamura H., Nakamura K., and Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 15 (1997) 351-369
6. Holmgren A. Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid. Redox Signal. 2 (2000) 811-820
7. Hirota K., Nakamura H., Masutani H., and Yodoi J. Thioredoxin superfamily and thioredoxin-inducing agents. Ann. N. Y. Acad. Sci. 957 (2002) 189-199
8. Kallis G.B., and Holmgren A. Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from Escherichia coli. J. Biol. Chem. 255 (1980) 10261-10265
9. Aslund F., Berndt K.D., and Holmgren A. Redox potentials of glutaredoxins and other thiol-disulfide oxidoreductases of the thioredoxin superfamily determined by direct protein-protein redox equilibria. J. Biol. Chem. 272 (1997) 30780-30786
10. Mossner E., Huber-Wunderlich M., Rietsch A., Beckwith J., Glockshuber R., and Aslund F. Importance of redox potential for the in vivo function of the cytoplasmic disulfide reductant thioredoxin from Escherichia coli. J. Biol. Chem. 274 (1999) 25254-25259
11. Carvalho A.P., Fernandes P.A., and Ramos M.J. Similarities and differences in the thioredoxin superfamily. Prog. Biophys. Mol. Biol. 91 (2006) 229-248
12. Lillig C.H., Berndt C., and Holmgren A. Glutaredoxin systems. Biochim. Biophys. Acta 1780 (2008) 1304-1317
13. Ellgaard L., and Ruddock L.W. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep. 6 (2005) 28-32
14. Funato Y., and Miki H. Nucleoredoxin, a novel thioredoxin family member involved in cell growth and differentiation. Antioxid. Redox Signal. 9 (2007) 1035-1057
15. Laurent T.C., Moore E.C., and Reichard P. Enzymatic synthesis of deoxyribonucleotides. IV. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J. Biol. Chem. 239 (1964) 3436-3444
16. Chae H.Z., Chung S.J., and Rhee S.G. Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 269 (1994) 27670-27678
17. Rhee S.G., Kang S.W., Chang T.S., Jeong W., and Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 52 (2001) 35-41
18. Stadtman E.R., Moskovitz J., Berlett B.S., and Levine R.L. Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism. Mol. Cell. Biochem. 234-235 (2002) 3-9
19. Lee S.-R., Yang K.-S., Kwon J., Lee C., Jeong W., and Rhee S.G. Regulation of PTEN by superoxide and H2O2 through the reversible formation of a disulfide between Cys124 and Cys71. J. Biol. Chem. 277 (2002) 20336-20342
20. Hirota K., Murata M., Sachi Y., Nakamura H., Takeuchi J., Mori K., and Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J. Biol. Chem. 274 (1999) 27891-27897
21. Takeuchi J., Hirota K., Itoh T., Shinkura R., Kitada K., Yodoi J., Namba T., and Fukuda K. Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase. Antioxid. Redox Signal. 2 (2000) 83-92
22. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17 (1998) 2596-2606
23. Gotoh Y., and Cooper J.A. Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction. J. Biol. Chem. 273 (1998) 17477-17482
24. Liu H., Nishitoh H., Ichijo H., and Kyriakis J.M. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol. Cell. Biol. 20 (2000) 2198-2208
25. Nishiyama A., Matsui M., Iwata S., Hirota K., Masutani H., Nakamura H., Takagi Y., Sono H., Gon Y., and Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 274 (1999) 21645-21650
26. Holmgren A. Hydrogen donor system for Escherichia coli ribonucleoside-diphosphate reductase dependent upon glutathione. Proc. Natl. Acad. Sci. USA 73 (1976) 2275-2279
27. Jeong W., Yoon H.W., Lee S.R., and Rhee S.G. Identification and characterization of TRP14, a thioredoxin-related protein of 14 kDa. New insights into the specificity of thioredoxin function. J. Biol. Chem. 279 (2004) 3142-3150
28. Kim J.R., Yoon H.W., Kwon K.S., Lee S.R., and Rhee S.G. Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH. Anal. Biochem. 283 (2000) 214-221
29. Luikenhuis S., Perrone G., Dawes I.W., and Grant C.M. The yeast Saccharomyces cerevisiae contains two glutaredoxin genes that are required for protection against reactive oxygen species. Mol. Biol. Cell 9 (1998) 1081-1091
30. Rodriguez-Manzaneque M.T., Ros J., Cabiscol E., Sorribas A., and Herrero E. Grx5 glutaredoxin plays a central role in protection against protein oxidative damage in Saccharomyces cerevisiae. Mol. Cell. Biol. 19 (1999) 8180-8190
31. Tamarit J., Belli G., Cabiscol E., Herrero E., and Ros J. Biochemical characterization of yeast mitochondrial Grx5 monothiol glutaredoxin. J. Biol. Chem. 278 (2003) 25745-25751
32. Lopreiato R., Facchin S., Sartori G., Arrigoni G., Casonato S., Ruzzene M., Pinna L.A., and Carignani G. Analysis of the interaction between piD261/Bud32, an evolutionarily conserved protein kinase of Saccharomyces cerevisiae, and the Grx4 glutaredoxin. Biochem. J. 377 (2004) 395-405
33. Izquierdo A., Casas C., Muhlenhoff U., Lillig C.H., and Herrero E. Saccharomyces cerevisiae Grx6 and Grx7 are monothiol glutaredoxins associated with the early secretory pathway. Eukaryot. Cell 7 (2008) 1415-1426
34. Fetrow J.S., Siew N., Di Gennaro J.A., Martinez-Yamout M., Dyson H.J., and Skolnick J. Genomic-scale comparison of sequence- and structure-based methods of function prediction: does structure provide additional insight?. Protein Sci. 10 (2001) 1005-1014
35. Mesecke N., Spang A., Deponte M., and Herrmann J.M. A novel group of glutaredoxins in the cis-Golgi critical for oxidative stress resistance. Mol. Biol. Cell 19 (2008) 2673-2680
36. Jiang S., Zhang S., Vuthiphandchai V., and Nimrat S. Human TRP14 gene homologue from amphioxus Branchiostoma belcheri: identification, evolution, expression and functional characterization. J. Anat. 210 (2007) 555-564
37. Ghaemmaghami S., Huh W.K., Bower K., Howson R.W., Belle A., Dephoure N., O'Shea E.K., and Weissman J.S. Global analysis of protein expression in yeast. Nature 425 (2003) 737-741
38. Huh W.K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W., Weissman J.S., and O'Shea E.K. Global analysis of protein localization in budding yeast. Nature 425 (2003) 686-691
39. Holmgren A. Tryptophan fluorescence study of conformational transitions of the oxidized and reduced form of thioredoxin. J. Biol. Chem. 247 (1972) 1992-1998
40. Krause G., and Holmgren A. Substitution of the conserved tryptophan 31 in Escherichia coli thioredoxin by site-directed mutagenesis and structure-function analysis. J. Biol. Chem. 266 (1991) 4056-4066
41. Slaby I., Cerna V., Jeng M.F., Dyson H.J., and Holmgren A. Replacement of Trp28 in Escherichia coli thioredoxin by site-directed mutagenesis affects thermodynamic stability but not function. J. Biol. Chem. 271 (1996) 3091-3096
42. Arner E.S., and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267 (2000) 6102-6109
43. Lee S.R., Bar-Noy S., Kwon J., Levine R.L., Stadtman T.C., and Rhee S.G. Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc. Natl. Acad. Sci. USA 97 (2000) 2521-2526
44. Spyrou G., Enmark E., Miranda-Vizuete A., and Gustafsson J. Cloning and expression of a novel mammalian thioredoxin. J. Biol. Chem. 272 (1997) 2936-2941
45. Lee S.R., Kim J.R., Kwon K.S., Yoon H.W., Levine R.L., Ginsburg A., and Rhee S.G. Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J. Biol. Chem. 274 (1999) 4722-4734
46. Eckers E., Bien M., Stroobant V., Herrmann J.M., and Deponte M. Biochemical characterization of dithiol glutaredoxin 8 from Saccharomyces cerevisiae: the catalytic redox mechanism redux. Biochemistry 48 (2009) 1410-1423
47. Lin T.Y. G33D mutant thioredoxin primarily affects the kinetics of reaction with thioredoxin reductase. Probing the structure of the mutant protein. Biochemistry 38 (1999) 15508-15513
48. Stubbe J., and Riggs-Gelasco P. Harnessing free radicals: formation and function of the tyrosyl radical in ribonucleotide reductase. Trends. Biochem. Sci. 23 (1998) 438-443
49. Woo J.R., Kim S.J., Jeong W., Cho Y.H., Lee S.C., Chung Y.J., Rhee S.G., and Ryu S.E. Structural basis of cellular redox regulation by human TRP14. J. Biol. Chem. 279 (2004) 48120-48125
50. Weichsel A., Gasdaska J.R., Powis G., and Montfort W.R. Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. Structure 4 (1996) 735-751
51. Qin J., Clore G.M., Kennedy W.M., Huth J.R., and Gronenborn A.M. Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B. Structure 3 (1995) 289-297
52. Qin J., Clore G.M., Kennedy W.P., Kuszewski J., and Gronenborn A.M. The solution structure of human thioredoxin complexed with its target from Ref-1 reveals peptide chain reversal. Structure 4 (1996) 613-620
53. Matthews J.R., Wakasugi N., Virelizier J.L., Yodoi J., and Hay R.T. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20 (1992) 3821-3830
54. Hayashi T., Ueno Y., and Okamoto T. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268 (1993) 11380-11388
55. Ueno M., Masutani H., Arai R.J., Yamauchi A., Hirota K., Sakai T., Inamoto T., Yamaoka Y., Yodoi J., and Nikaido T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem. 274 (1999) 35809-35815
56. Ueno M., Matsutani Y., Nakamura H., Masutani H., Yagi M., Yamashiro H., Kato H., Inamoto T., Yamauchi A., Takahashi R., Yamaoka Y., and Yodoi J. Possible association of thioredoxin and p53 in breast cancer. Immunol. Lett. 75 (2000) 15-20
57. Grippo J.F., Tienrungroj W., Dahmer M.K., Housley P.R., and Pratt W.B. Evidence that the endogenous heat-stable glucocorticoid receptor-activating factor is thioredoxin. J. Biol. Chem. 258 (1983) 13658-13664
58. Makino Y., Okamoto K., Yoshikawa N., Aoshima M., Hirota K., Yodoi J., Umesono K., Makino I., and Tanaka H. Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system. J. Clin. Invest. 98 (1996) 2469-2477
59. Makino Y., Yoshikawa N., Okamoto K., Hirota K., Yodoi J., Makino I., and Tanaka H. Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J. Biol. Chem. 274 (1999) 3182-3188
60. Hayashi S., Hajiro-Nakanishi K., Makino Y., Eguchi H., Yodoi J., and Tanaka H. Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res. 25 (1997) 4035-4040
61. Akamatsu Y., Ohno T., Hirota K., Kagoshima H., Yodoi J., and Shigesada K. Redox regulation of the DNA binding activity in transcription factor PEBP2. The roles of two conserved cysteine residues. J. Biol. Chem. 272 (1997) 14497-14500
62. Abate C., Patel L., Rauscher F.J., and Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249 (1990) 1157-1161
63. Finkel T. Oxygen radicals and signaling. Curr. Opin. Cell Biol. 10 (1998) 248-253
64. Rhee S.G. Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31 (1999) 53-59
65. Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15 (2003) 247-254
66. 2, a necessary evil for cell signaling. Science 312 (2006) 1882-1883
67. Meier B., Radeke H.H., Selle S., Younes M., Sies H., Resch K., and Habermehl G.G. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem. J. 263 (1989) 539-545
68. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10 (1991) 2247-2258
69. Oakley F.D., Abbott D., Li Q., and Engelhardt J. Signaling components of redox active endosomes: the redoxosomes. Antioxid. Redox Signal. 11 (2009) 1313-1333
70. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635
71. Garg A.K., and Aggarwal B.B. Reactive oxygen intermediates in TNF signaling. Mol. Immunol. 39 (2002) 509-517
72. Schulze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jacob W.A., and Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267 (1992) 5317-5323
73. Shoji Y., Uedono Y., Ishikura H., Takeyama N., and Tanaka T. DNA damage induced by tumour necrosis factor-alpha in L929 cells is mediated by mitochondrial oxygen radical formation. Immunology 84 (1995) 543-548
74. Goossens V., Grooten J., De Vos K., and Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. USA 92 (1995) 8115-8119
75. Fernandez-Checa J.C., Kaplowitz N., Garcia-Ruiz C., Colell A., Miranda M., Mari M., Ardite E., and Morales A. GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am. J. Physiol. 273 (1997) G7-G17
76. Matsuda M., Masutani H., Nakamura H., Miyajima S., Yamauchi A., Yonehara S., Uchida A., Irimajiri K., Horiuchi A., and Yodoi J. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J. Immunol. 147 (1991) 3837-3841
77. Liu Y., and Min W. Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ. Res. 90 (2002) 1259-1266
78. Hashimoto S., Matsumoto K., Gon Y., Furuichi S., Maruoka S., Takeshita I., Hirota K., Yodoi J., and Horie T. Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 258 (1999) 443-447
79. Ueda S., Masutani H., Nakamura H., Tanaka T., Ueno M., and Yodoi J. Redox control of cell death. Antioxid. Redox Signal. 4 (2002) 405-414
80. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev. 18 (2004) 2195-2224
81. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6853-6866
82. Li N., and Karin M. Is NF-kappaB the sensor of oxidative stress?. FASEB J. 13 (1999) 1137-1143
83. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59 (2000) 13-23
84. Bonizzi G., Piette J., Merville M.P., and Bours V. Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1. Biochem. Pharmacol. 59 (2000) 7-11
85. Korn S.H., Wouters E.F., Vos N., and Janssen-Heininger Y.M. Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase. J. Biol. Chem. 276 (2001) 35693-35700
86. Jaspers I., Zhang W., Fraser A., Samet J.M., and Reed W. Hydrogen peroxide has opposing effects on IKK activity and IkappaBalpha breakdown in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 24 (2001) 769-777
87. Harper R., Wu K., Chang M.M., Yoneda K., Pan R., Reddy S.P., and Wu R. Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetyl-cysteine and glutathione. Am. J. Respir. Cell Mol. Biol. 25 (2001) 178-185
88. Kabe Y., Ando K., Hirao S., Yoshida M., and Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Signal. 7 (2005) 395-403
89. Jeong W., Chang T.S., Boja E.S., Fales H.M., and Rhee S.G. Roles of TRP14, a thioredoxin-related protein in tumor necrosis factor-alpha signaling pathways. J. Biol. Chem. 279 (2004) 3151-3159
90. Brigelius-Flohe R., Banning A., Kny M., and Bol G.F. Redox events in interleukin-1 signaling. Arch. Biochem. Biophys. 423 (2004) 66-73
91. Asehnoune K., Strassheim D., Mitra S., Kim J.Y., and Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J. Immunol. 172 (2004) 2522-2529
92. Hayakawa M., Miyashita H., Sakamoto I., Kitagawa M., Tanaka H., Yasuda H., Karin M., and Kikugawa K. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J. 22 (2003) 3356-3366
93. Crepieux P., Kwon H., Leclerc N., Spencer W., Richard S., Lin R., and Hiscott J. I kappaB alpha physically interacts with a cytoskeleton-associated protein through its signal response domain. Mol. Cell. Biol. 17 (1997) 7375-7385
94. Jung Y., Kim H., Min S.H., Rhee S.G., and Jeong W. Dynein light chain LC8 negatively regulates NF-kappaB through the redox-dependent interaction with IkappaBalpha. J. Biol. Chem. 283 (2008) 23863-23871
95. Liang J., Jaffrey S.R., Guo W., Snyder S.H., and Clardy J. Structure of the PIN/LC8 dimer with a bound peptide. Nat. Struct. Biol. 6 (1999) 735-740
96. Tochio H., Ohki S., Zhang Q., Li M., and Zhang M. Solution structure of a protein inhibitor of neuronal nitric oxide synthase. Nat. Struct. Biol. 5 (1998) 965-969
97. King S.M. Dynein-independent functions of DYNLL1/LC8: redox state sensing and transcriptional control. Sci. Signal. 1 (2008) pe51
98. Nyarko A., Cochrun L., Norwood S., Pursifull N., Voth A., and Barbar E. Ionization of His 55 at the dimer interface of dynein light-chain LC8 is coupled to dimer dissociation. Biochemistry 44 (2005) 14248-14255
99. Vadlamudi R.K., Bagheri-Yarmand R., Yang Z., Balasenthil S., Nguyen D., Sahin A.A., den Hollander P., and Kumar R. Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes. Cancer Cell 5 (2004) 575-585
100. Song Y., Benison G., Nyarko A., Hays T.S., and Barbar E. Potential role for phosphorylation in differential regulation of the assembly of dynein light chains. J. Biol. Chem. 282 (2007) 17272-17279
101. Song C., Wen W., Rayala S.K., Chen M., Ma J., Zhang M., and Kumar R. Serine 88 phosphorylation of the 8-kDa dynein light chain 1 is a molecular switch for its dimerization status and functions. J. Biol. Chem. 283 (2008) 4004-4013
102. Natoli G., Costanzo A., Ianni A., Templeton D.J., Woodgett J.R., Balsano C., and Levrero M. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275 (1997) 200-203
103. Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11 (2001) 372-377
104. Tobiume K., Matsuzawa A., Takahashi T., Nishitoh H., Morita K., Takeda K., Minowa O., Miyazono K., Noda T., and Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2 (2001) 222-228
105. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
106. Salmeen A., Andersen J.N., Myers M.P., Meng T.C., Hinks J.A., Tonks N.K., and Barford D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423 (2003) 769-773
107. van Montfort R.L., Congreve M., Tisi D., Carr R., and Jhoti H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 423 (2003) 773-777
108. Lee S.R., Kwon K.S., Kim S.R., and Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273 (1998) 15366-15372
109. Meng T.C., Fukada T., and Tonks N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9 (2002) 387-399
110. Sanchez-Perez I., Martinez-Gomariz M., Williams D., Keyse S.M., and Perona R. CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin. Oncogene 19 (2000) 5142-5152
111. Tanoue T., Moriguchi T., and Nishida E. Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J. Biol. Chem. 274 (1999) 19949-19956
112. Tanoue T., Yamamoto T., Maeda R., and Nishida E. A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs. J. Biol. Chem. 276 (2001) 26629-26639
113. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
114. Hampton M.B., Fadeel B., and Orrenius S. Redox regulation of the caspases during apoptosis. Ann. N. Y. Acad. Sci. 854 (1998) 328-335
115. Wilson K.P., Black J.A., Thomson J.A., Kim E.E., Griffith J.P., Navia M.A., Murcko M.A., Chambers S.P., Aldape R.A., Raybuck S.A., et al. Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370 (1994) 270-275
116. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., and Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275 (1997) 90-94
117. Hatai T., Matsuzawa A., Inoshita S., Mochida Y., Kuroda T., Sakamaki K., Kuida K., Yonehara S., Ichijo H., and Takeda K. Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria-dependent caspase activation. J. Biol. Chem. 275 (2000) 26576-26581
118. Puthalakath H., Huang D.C., O'Reilly L.A., King S.M., and Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3 (1999) 287-296
119. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47 Pt. 2 (1991) 110-119